Primsol

Primsol is a brand name of trimethoprim, approved by the FDA in the following formulation(s):

PRIMSOL (trimethoprim hydrochloride - solution; oral)

• 
  Manufacturer: FSC
  
  Approval date: January 24, 2000
  
  Strength(s): EQ 50MG BASE/5ML ^[RLD]

Has a generic version of Primsol been approved?

No. There is currently no therapeutically equivalent version of Primsol available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Primsol. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Pleasant-tasting aqueous liquid composition of a bitter-tasting drug
  Patent 5,763,449
  Issued: June 9, 1998
  Inventor(s): Anaebonam; Aloysius O. & Clemente; Emmett & Fawzy; Abdel A.
  Assignee(s): Ascent Pediatrics, Inc.
  A liquid pharmaceutical composition is contemplated that comprises a pharmaceutically effective amount of a bitter tasting drug dissolved or dispersed in an aqueous medium that is free of ethanol. That aqueous medium consists essentially of water, about 5 to about 30 weight percent polyvinylpyrrolidone, about 45 to about 55 weight percent of a C.sub.3 -C.sub.6 polyol, about 0.01 to about 0.5 weight percent ammonium glycyrrhizinate and one or more flavorants. The liquid composition is transparent and has a pleasant taste.
  
  Patent expiration dates:
  
  
  • August 7, 2016
    
  
  



• 
  Pleasant-tasting aqueous liquid composition of a bitter-tasting drug
  Patent 5,962,461
  Issued: October 5, 1999
  Inventor(s): Anaebonam; Aloysius O. & Clemente; Emmett & Fawzy; Abdel A.
  Assignee(s): Ascent Pediatrics, Inc.
  A liquid pharmaceutical composition is contemplated that comprises a pharmaceutically effective amount of a bitter tasting drug dissolved or dispersed in an aqueous medium that is free of ethanol. That aqueous medium consists essentially of water, about 5 to about 30 weight percent polyvinylpyrrolidone, about 35 to about 55 weight percent of a C.sub.3 -C.sub.6 polyol, about 0.01 to about 0.5 weight percent ammonium glycyrrhizinate and one or more flavorants. The liquid composition is transparent and has a pleasant taste. The bitter tasting drugs claimed herein are vitamin and mineral preparations, trimethoprim, and guaifenesin.
  
  Patent expiration dates:
  
  
  • August 7, 2016
    
  
  

See also...

• Primsol Solution Consumer Information (Wolters Kluwer)
• Primsol Consumer Information (Cerner Multum)
• Primsol Advanced Consumer Information (Micromedex)
• Trimethoprim Consumer Information (Wolters Kluwer)
• Trimethoprim Solution Consumer Information (Wolters Kluwer)
• Trimethoprim Consumer Information (Cerner Multum)
• Trimethoprim Advanced Consumer Information (Micromedex)
• Trimethoprim AHFS DI Monographs (ASHP)